3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
122
Squamous Cell Carcinoma of Head and Neck
60
Melanoma
57
Parkinson Disease 4, Autosomal Dominant Lewy Body
47
Lung Neoplasms
46
Triple Negative Breast Neoplasms
44
Neoplasm Metastasis
44
Breast Neoplasms
40
Neoplasms
38
Colorectal Neoplasms
33
Head and Neck Neoplasms
27
Carcinoma, Renal Cell
27
Endometrial Neoplasms
26
Carcinoma, Transitional Cell
24
Ovarian Neoplasms
23
Urinary Bladder Neoplasms
21
Stomach Neoplasms
16
Carcinoma
15
Pancreatic Neoplasms
14
Uterine Cervical Neoplasms
12
Recurrence
12
Esophageal Neoplasms
12
Sarcoma
11
Hodgkin Disease
11
Brain Neoplasms
11
Cholangiocarcinoma
10
Carcinoma, Squamous Cell
10
Carcinoma, Hepatocellular
9
Skin Neoplasms
8
Prostatic Neoplasms
8
Interventions
liposomal doxorubicin
1
fludarabine
1
dostarlimab
1
Paclitaxel
1
Nivolumab
1
Ipilimumab
1
Gemcitabine
1
Doxorubicin
1
Dexamethasone
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma, Clear Cell
×
pembrolizumab
×
90 days
×
Clear all
No trials found.